Farallon Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $172M | Sell |
|
|||||
|
2023
Q1 | $172M | Buy |
|
|||||
|
2022
Q4 | $164M | Buy |
|
|||||
|
2022
Q3 | $81.6M | Buy |
|
|||||
|
2022
Q2 | $56.8M | Buy |
|
|||||
|
2022
Q1 | $41.7M | Buy |
|
|||||
|
2021
Q4 | $35.4M | Sell |
|
|||||
|
2021
Q3 | $48.4M | Buy |
|
|||||
|
2021
Q2 | $37.7M | Buy |
|
|||||
|
2021
Q1 | $28.8M | Hold |
|
|||||
|
2020
Q4 | $25.2M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $72.3M | Sell |
|
|||||
|
2018
Q1 | $93.1M | Sell |
|
|||||
|
2017
Q4 | $172M | Buy |
|
|||||
|
2017
Q3 | $149M | Buy |
|
|||||
|
2017
Q2 | $57.7M | Buy |
|